CBD Could be an Effective Treatment for Opioid Addiction | Kannabi - The Culture of Cannabis
A new study shows CBD as an effective treatment for opioid addiction.
A team of researchers explored the potential of CBD to reduce the cravings and anxiety from users. The withdraw process include anxiety and cravings, which are often reasons why individuals relapse or continue drug use.
The U.S has been dealing with the opioid epidemic for decades. Medicines used to curb cravings are still considered to be opioids, which is not a sustainable treatment. Along with medication, patients must frequently visit their practitioners for check-ups. The process can deter people from wanting to get clean.
According to the U.S Department of Health and Human Sciences, “Opioid overdoses accounted for more than 42,000 deaths in 2016, more than any previous year on record. An estimated 40% of opioid overdose deaths involved a prescription opioid.” The CDC claims heroin as a “semi-synthetic, highly addictive opioid that is made from morphine, a substance taken from opium poppy plants, and can produce intense feelings of euphoria.”
The study, published by the American Journal of Psychiatry, was lead by Yasim Hurd and her colleagues. They held a trial for 42 adults who recently had a history with heroin addiction and were not taking prescribed medication for treatment. The participants had to withhold from heroin use for the entire trial period.
Individuals who had been using heroin for an average of 13 years, were recruited from treatment centers, halfway houses, and social services. They had only gone less than a month without using the drug.
The participants were divided randomly into three groups. They administered the CBD was by giving one group a placebo, another group 400 milligrams of CBD, and the other 800 milligrams of CBD for three days in a row. They followed this over for the next two weeks.
During their trial period, sessions were held where they were shown images that were drug-related and other pictures of nature. The individuals were then analyzed by having to rate their craving levels and anxiety. The researchers also examined their heart rates and stress levels. The study showed that the groups who had received CBD had significantly lower levels.
Hurd claimed that the group that was administered CBD had a 2 to 3-fold reduction in their cravings when compared to the group that was given placebo.
The conclusion stated, “CBD’s potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.